Leukotriene B4 in hemodialysis.

Artif Organs

Laboratoire d'Immunologie, Faculté Médecine Pharmacie, Clermont-Ferrand, France.

Published: October 1990

AI Article Synopsis

Article Abstract

Leukotrienes are eicosanoids arising from arachidonic acid via 5 lipooxygenase, an enzyme essentially present in leukocyte cells. Leukotriene B4 might be an indicator of neutropolymorphonuclear leukocyte activation when there is contact with artificial membranes. The level of plasmatic leukotriene B4 was measured at three different times during the hemodialysis treatment in several patients undergoing dialysis on three different membranes (one cellulosic and two synthetics). A moderate increase of leukotriene B4 was observed early (at 15 min), comparable among the three membranes, but levels returned to baseline at 180 min. Leukotriene B4 production proved leukocyte activation and was probably related to a direct interaction with dialysis membrane. Nevertheless, complement intervention could not be excluded. Leukotriene B4 is one molecule more among the group of inflammatory mediators produced during hemodialysis treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1525-1594.1990.tb02986.xDOI Listing

Publication Analysis

Top Keywords

leukocyte activation
8
hemodialysis treatment
8
three membranes
8
leukotriene
6
leukotriene hemodialysis
4
hemodialysis leukotrienes
4
leukotrienes eicosanoids
4
eicosanoids arising
4
arising arachidonic
4
arachidonic acid
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!